Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

925 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study.
Griffith DE, Eagle G, Thomson R, Aksamit TR, Hasegawa N, Morimoto K, Addrizzo-Harris DJ, O'Donnell AE, Marras TK, Flume PA, Loebinger MR, Morgan L, Codecasa LR, Hill AT, Ruoss SJ, Yim JJ, Ringshausen FC, Field SK, Philley JV, Wallace RJ Jr, van Ingen J, Coulter C, Nezamis J, Winthrop KL; CONVERT Study Group. Griffith DE, et al. Among authors: hasegawa n. Am J Respir Crit Care Med. 2018 Dec 15;198(12):1559-1569. doi: 10.1164/rccm.201807-1318OC. Am J Respir Crit Care Med. 2018. PMID: 30216086 Clinical Trial.
Amikacin liposome inhalation suspension for Mycobacterium avium complex pulmonary disease: A subgroup analysis of Japanese patients in the randomized, phase 3, CONVERT study.
Morimoto K, Nonaka M, Yamazaki Y, Nakagawa T, Takasaki J, Tsuyuguchi K, Kitada S, Jumadilova Z, Yuen DW, Ciesielska M, Hasegawa N. Morimoto K, et al. Among authors: hasegawa n. Respir Investig. 2024 Mar;62(2):284-290. doi: 10.1016/j.resinv.2023.12.012. Epub 2024 Jan 25. Respir Investig. 2024. PMID: 38277865 Free article. Clinical Trial.
Distinctive clinical features of radiological pleuroparenchymal fibroelastosis with nontuberculous mycobacterial pulmonary disease: A multicenter retrospective cohort study.
Tanaka H, Asakura T, Okamori S, Furuuchi K, Yagi M, Nakayama Y, Kuramoto J, Yagi K, Hase I, Kamata H, Fujiwara K, Nakao A, Masugi Y, Sato Y, Kanai Y, Namkoong H, Fukunaga K, Nakagawa T, Morimoto K, Fujita M, Hasegawa N. Tanaka H, et al. Among authors: hasegawa n. Int J Infect Dis. 2024 Nov;148:107233. doi: 10.1016/j.ijid.2024.107233. Epub 2024 Sep 4. Int J Infect Dis. 2024. PMID: 39241955 Free article.
Development of allergic bronchopulmonary aspergillosis in a patient with nontuberculous mycobacterial-pulmonary disease successfully treated with dupilumab: A case report and literature review.
Onozato R, Miyata J, Asakura T, Namkoong H, Asano K, Hasegawa N, Fukunaga K. Onozato R, et al. Among authors: hasegawa n. Respirol Case Rep. 2024 Jul 9;12(7):e01432. doi: 10.1002/rcr2.1432. eCollection 2024 Jul. Respirol Case Rep. 2024. PMID: 38988827 Free PMC article.
Lung volume measurement using chest CT in COVID-19 patients: a cohort study in Japan.
Otake S, Shiraishi Y, Chubachi S, Tanabe N, Maetani T, Asakura T, Namkoong H, Shimada T, Azekawa S, Nakagawara K, Tanaka H, Fukushima T, Watase M, Terai H, Sasaki M, Ueda S, Kato Y, Harada N, Suzuki S, Yoshida S, Tateno H, Yamada Y, Jinzaki M, Hirai T, Okada Y, Koike R, Ishii M, Hasegawa N, Kimura A, Imoto S, Miyano S, Ogawa S, Kanai T, Fukunaga K. Otake S, et al. Among authors: hasegawa n. BMJ Open Respir Res. 2024 Apr 24;11(1):e002234. doi: 10.1136/bmjresp-2023-002234. BMJ Open Respir Res. 2024. PMID: 38663888 Free PMC article.
The first Japanese case of autosomal dominant cutis laxa with a frameshift mutation in exon 30 of the elastin gene complicated by small airway disease with 8 years of follow-up.
Kaji M, Namkoong H, Chubachi S, Tanaka H, Asakura T, Haraguchi Hashiguchi M, Yamada M, Uehara T, Suzuki H, Tanabe N, Yamada Y, Nozaki T, Ouchi T, Tsuji A, Kosaki K, Hasegawa N, Fukunaga K. Kaji M, et al. Among authors: hasegawa n. BMC Pulm Med. 2024 Oct 1;24(1):481. doi: 10.1186/s12890-024-03290-5. BMC Pulm Med. 2024. PMID: 39354494 Free PMC article.
Prognostic significance of chronic kidney disease and impaired renal function in Japanese patients with COVID-19.
Tanaka H, Chubachi S, Asakura T, Namkoong H, Azekawa S, Otake S, Nakagawara K, Fukushima T, Lee H, Watase M, Sakurai K, Kusumoto T, Masaki K, Kamata H, Ishii M, Hasegawa N, Okada Y, Koike R, Kitagawa Y, Kimura A, Imoto S, Miyano S, Ogawa S, Kanai T, Fukunaga K. Tanaka H, et al. Among authors: hasegawa n. BMC Infect Dis. 2024 May 25;24(1):527. doi: 10.1186/s12879-024-09414-w. BMC Infect Dis. 2024. PMID: 38796423 Free PMC article.
Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF®, a Phase II randomised, double-blind, placebo-controlled, dose-finding study.
Chalmers JD, Shteinberg M, Mall MA, O'Donnell AE, Watz H, Gupta A, Frahm E, Eleftheraki A, Rauch J, Chotirmall SH, Armstrong AW, Eickholz P, Hasegawa N, Sauter W, McShane PJ. Chalmers JD, et al. Among authors: hasegawa n. Eur Respir J. 2024 Oct 28:2401551. doi: 10.1183/13993003.01551-2024. Online ahead of print. Eur Respir J. 2024. PMID: 39255990 Free article.
925 results